The Rome News Tribune reported on Sunday that merger plans between Atrium Health Floyd and the Harbin Clinic remain on hold pending a Federal Trade Commission review.
The proposal, which had undergone an initial review by the federal agency, appeared to be close to fruition until October when the FTC stepped in to take a closer look at the proposal.
Whenever two healthcare companies report a proposed deal, the FTC or Department of Justice will do a preliminary review to determine whether it raises any antitrust concerns that warrant closer examination.
If the initial review raises a concern regarding competition, the agency can opt to take a closer look at how the merger will affect competitive practices in the area.
Both Atrium and Harbin have stated that they remain committed to the merger plans.
Comments